{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:37:41Z","timestamp":1758638261871},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T00:00:00Z","timestamp":1305849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/eye.2011.115","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T09:45:48Z","timestamp":1305884748000},"page":"1034-1038","source":"Crossref","is-referenced-by-count":23,"title":["One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration"],"prefix":"10.1038","volume":"25","author":[{"given":"S","family":"Arora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"McKibbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,20]]},"reference":[{"key":"BFeye2011115_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials\u2013TAP report","year":"1999","unstructured":"Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials\u2013TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 1999; 117: 1329\u20131345.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2011115_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. Ranibizumab for neovascular age related macular degeneration. N Engl J Med 2006; 355: 1419\u20131431.","journal-title":"N Engl J Med"},{"key":"BFeye2011115_CR3","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432\u20131444.","journal-title":"N Engl J Med"},{"key":"BFeye2011115_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/archopht.121.9.1253","volume":"121","author":"I Barbazetto","year":"2003","unstructured":"Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD et al., Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. Arch Ophthalmol 2003; 121: 1253\u20131268.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"BFeye2011115_CR5","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/eye.2009.265","volume":"24","author":"M Ritter","year":"2009","unstructured":"Ritter M, Bolz M, Sacu S, Dea\u2019k G, Kiss C, Pruente C et al. Effect of intravitreal ranibizumab in avascular pigment epithelial detachment. Eye (Lond) 2009; 24 (6): 962\u2013968.","journal-title":"Eye (Lond)"},{"key":"BFeye2011115_CR6","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1038\/eye.2008.425","volume":"23","author":"A Lommatzsch","year":"2009","unstructured":"Lommatzsch A, Heimes B, Gutfleisch M, Spital G, Zeimer M, Pauleikhoff D . Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments. Eye 2009; 23: 2163\u20132168.","journal-title":"Eye"},{"key":"BFeye2011115_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/IAE.0b013e31817d5d03","volume":"28","author":"A Chiang","year":"2008","unstructured":"Chiang A, Chang LK, Yu F, Sarraf D . Predictors of anti-VEGF associated retinal pigment epithelial tear using FA and OCT analysis. Retina 2008; 28: 1265\u20131269.","journal-title":"Retina"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2011115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2011115","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2011115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:12:58Z","timestamp":1684429978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2011115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,20]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["BFeye2011115"],"URL":"https:\/\/doi.org\/10.1038\/eye.2011.115","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,20]]}}}